Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters (Q39002313)

8 September 2017

Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters (English)

1 reference

8 September 2017

Raphaelle Fanciullino

1

1 reference

8 September 2017

Severine Mollard

2

1 reference

8 September 2017

Florian Correard

3

1 reference

8 September 2017

Sarah Giacometti

4

1 reference

8 September 2017

Cindy Serdjebi

5

1 reference

8 September 2017

Athanassios Iliadis

6

1 reference

8 September 2017

Joseph Ciccolini

7

1 reference

8 September 2017

22 April 2014

1 reference

8 September 2017

Pharmaceutical Research

1 reference

8 September 2017

31

1 reference

8 September 2017

2677-2684

1 reference

8 September 2017

10

1 reference

Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function

8 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Passive and active tumour targeting with nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Nanoparticles in drug delivery: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Pharmacokinetics and biodistribution of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Passive and active drug targeting: drug delivery to tumors as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1364-9

Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes

21 January 2018

1 reference

12 December 2020

Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts

1 reference

12 December 2020

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

12 December 2020

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

12 December 2020

In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation

1 reference

12 December 2020

Long-circulating and target-specific nanoparticles: theory to practice

1 reference

12 December 2020

Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo.

1 reference

12 December 2020

10.1007/S11095-014-1364-9

Identifiers

DOI

1 reference

8 September 2017

1 reference